Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 217.79B P/E 28.54 EPS this Y 8.30% Ern Qtrly Grth 40.20%
Income 10.08B Forward P/E 13.66 EPS next Y 10.00% 50D Avg Chg 2.00%
Sales 48.86B PEG 2.02 EPS past 5Y 6.39% 200D Avg Chg 11.00%
Dividend 3.00% Price/Book 40.99 EPS next 5Y 7.60% 52W High Chg -3.00%
Recommedations 2.90 Quick Ratio 0.61 Shares Outstanding 2.02B 52W Low Chg 39.00%
Insider Own 0.00% ROA 8.86% Shares Float 1.93B Beta 0.50
Inst Own 6.93% ROE 21.50% Shares Shorted/Prior 5.32M/5.87M Price 102.75
Gross Margin 75.55% Profit Margin 33.11% Avg. Volume 1,891,108 Target Price 117.68
Oper. Margin 33.41% Earnings Date Oct 29 Volume 803,746 Change -0.55%
About Novartis AG

Novartis AG engages in the research, development, manufacture, and marketing of healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. The company also provides Pluvicto, lutetium Lu 177 vipivotide tetraxetan, indicated for the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer; and Lutathera, lutetium Lu 177 dotatate, a prescription medicine used to treat adults and children aged 12 years and older with gastroenteropancreatic neuroendocrine tumors. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol; and Dawn Health for the development and commercialization of Ekiva, a digital solution designed for people living with Paroxysmal Nocturnal Hemoglobinuria. The company was incorporated in 1996 and is headquartered in Basel, Switzerland.

Novartis AG News
11/15/24 FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
11/15/24 Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus
11/15/24 Here's Why Novartis (NVS) is a Strong Value Stock
11/15/24 Ouch: Why a Healthcare Selloff Really Hurts in Europe
11/14/24 Down -10.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS)
11/14/24 Zacks.com featured highlights include Janus Henderson, Coastal Financial, Novartis, Apogee and InterDigital
11/13/24 Novartis (NVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
11/13/24 Down -9.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS)
11/13/24 5 Low-Leverage Stocks to Buy Amid the Focus on Inflation Data
11/13/24 Q3 2024 Voyager Therapeutics Inc Earnings Call
11/13/24 Schrodinger announces expanded license agreement with Novartis
11/13/24 Amgen shares sink on obesity drug concerns; AstraZeneca to spend $3.5B on manufacturing
11/13/24 Q3 2024 Legend Biotech Corp Earnings Call
11/13/24 Schrodinger Inc (SDGR) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
11/13/24 Q3 2024 Schrodinger Inc Earnings Call
11/12/24 Top Stock Reports for Netflix, Salesforce & Cisco
11/12/24 Schrödinger Scores Big Despite Q3 Miss As Novartis Collaboration Promises Billions In Milestones: Details
11/11/24 NVS or LLY: Which Is the Better Value Stock Right Now?
11/08/24 Nektar Q3 Loss Narrower Than Expected, Pipeline Development in Focus
11/08/24 Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus
NVS Chatroom

User Image Bullrider88 Posted - 14 hours ago

$CERO $NVDL $NVLN $NVS $NWBO For all cancer patients For humanity Support the cause And burn the shorts who deserve karma by shorting a bio stock. 0 shorts covered Fda approval on friday. Cancer cure = big money 13g just filed 15% of total shares.

User Image iQuicky Posted - 1 day ago

$NVS gradually

User Image raleigh_trader Posted - 1 day ago

Pharma getting CRUSHED. Some good long term opportunities opening up $ABBV $NVO $NVS $MRK $LLY although I’d like to see a little more come of Lilly. Not a bad starter position here under 750 though.

User Image kingwest_00 Posted - 2 days ago

$BLK this is heavy in $msft and pharma, $NVS $MRK $AZN, with the FTC and RFK Jr, it could get hurt.

User Image valueforme Posted - 2 days ago

$ALNY $NVS $CDXS I told ya - inclisiran

User Image TheaStein Posted - 2 days ago

$NVS https://www.globenewswire.com/news-release/2024/11/12/2979299/0/en/Mainz-Biomed-and-Thermo-Fisher-Scientific-Sign-a-Collaboration-Agreement-for-the-Development-of-Next-Generation-Colorectal-Cancer-Screening-Product-for-Global-Markets.html

User Image Capitulation_0 Posted - 2 days ago

$NVS Has come down far enough.. I'm buying. Short hospitals, PBMs.

User Image joachim52 Posted - 3 days ago

$TGTX $NVS $RHHBY $GSK $AZN rumoured to be in the race. If there is already a bid over 60 USD / share this will get bought out at 80 USD plus … just my two cents … 66 USD / share makes the CEO Mr. Weiss a billionaire! That’s interesting!

User Image MRTunity Posted - 3 days ago

$TGTX if MW can play this right, he can use buybacks and shorts covering to shoot stock up toward $45-$50 and then demand closer to $75-$90 than $60 rumoured especially if multiple bidders $RHHBY $GSK $NVS 🤑

User Image seforim Posted - 3 days ago

$INCY $KPTI $NVS $GSK $ABBV https://x.com/kinatsofrim/status/1856798975438807079

User Image TerranceLyles191 Posted - 3 days ago

$NVS KSCP’s competitors keep setting benchmarks, while we seem to be lagging behind in the innovation race.

User Image Avocado_smash Posted - 3 days ago

$MNOV Wait and hold until the company announce the detail of the settlement from $NVS $SNY, this is huge, imo. https://investors.medicinova.com/news-releases/news-release-details/medicinova-given-notice-monetary-damages-due-under-patent

User Image Avocado_smash Posted - 4 days ago

$MNOV MNOV MC only 75M vs $NVS Zolgensma yearly revenue of 1.3B per year since 2021 in 45 country, the amount of settlement might be bigger than the company MC.

User Image WTech48 Posted - 4 days ago

$MNOV suprised this has not moved on news of $NVS payout $SPY

User Image shavitmi Posted - 4 days ago

$SDGR big news with $NVS Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties. Great AI company that help discover new drugs

User Image shavitmi Posted - 4 days ago

$SDGR if they work with $NVS Schrödinger to receive $150 million upfront and eligible to receive up to approximately $2.3 billion in milestone payments plus royalties. Maybe other big pharma will follow Future is AI also in drug discovery $NVDA

User Image seforim Posted - 5 days ago

$ABBV $INCY $NVS $PFE $GSK https://x.com/kinatsofrim/status/1856058162064851035

User Image iQuicky Posted - 5 days ago

$NVS pretty

User Image Fingerlickengood Posted - 6 days ago

$QBTS $NVS $JNJ $PFE Pretty AMAZING! https://www.nature.com/articles/d43747-023-00021-3

User Image Fingerlickengood Posted - 6 days ago

$PLTR $IONQ $NVS $QBTS Are you kidding me....they are sitting on this!! https://www.nature.com/articles/d43747-023-00021-3

User Image NoRisksNoFun Posted - 1 week ago

$VKTX will $NVS buy em out?

User Image iQuicky Posted - 1 week ago

$NVS added

User Image Trader2004 Posted - 1 week ago

@CaptainAmrica You brag about your expertise says so in profile...Yet don't acknowledge a Ceo who led a department at $NVS 14 yrs 100m - 8 b in sales...I guess folks like this jump to losers right ?

User Image RoidRagingBull Posted - 1 week ago

@kadinnguyen @VoodooValve I’ll take 1 for 1 share exchange… in this order🤑. $NVS - Wild card $MRK - They are hunting obesity/mash. $GILD - Nash/Mash fits well. $AZN - Least favorite but highly likely.

User Image Alec_Ram Posted - 1 week ago

$AZN $NVS 🚨 MYNZ HUGE PR drop incoming before the Nov 13 meeting 🔥 Someone is pushing these dates of upcoming NEWS 3 biggest stock alert channels announced, might consider to add now, who knows.

User Image FrankShea1094 Posted - 1 week ago

$NVS AITX's ability to continuously set new trends is impressive, but it's also a reminder of KSCP’s current shortcomings in innovation.

User Image buzz_kill Posted - 1 week ago

@TheBullishTrade I think you meant $NVS because $NVO is Novo-Nordisk.

User Image stockraider1989 Posted - 1 week ago

$AZB $NVS MYNZ +10.91% PM LFG, unusually high volume activity last week, apx 30% more than average. 👇😘🚀 This stock may see the last time this price per share PT $5+ 🚀 HUGE PRs drop incoming before the Nov 13 meeting, so compliance is coming—no RS needed. Here is why… 1.Frankie Muniz backing Mainz (yes, the Malcolm guy & NASCAR #33 now repping MYNZ). 2.Petra, ex-Obama advisor, hinted at a big U.S. lab partner. Solid source! 3.Six news hits in 3 weeks—momentum. 4.Already solid in the EU, not new but expanding, with insurance covering their tests. 5.Their test has 88% accuracy vs. EXAS (42%) & GH (20%)—big edge! 6.$1.5M private placement in the bag. 7.CEO teased big plans ahead.

User Image NoRisksNoFun Posted - 1 week ago

$PFE $MRNA $AZN $NVS

User Image AlertsAndNews Posted - 2 weeks ago

$NVS Novartis CEO 'very confident' on sales target, doesn't fear patent cliff - newspaper https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-ceo-very-confident-sales-target-doesnt-fear-patent-cliff-newspaper-2024-11-02/

Analyst Ratings
B of A Securities Neutral Sep 11, 24
Goldman Sachs Neutral Sep 5, 24
Jefferies Hold Sep 3, 24
Jefferies Buy Jul 2, 24
BMO Capital Market Perform Apr 24, 24
BMO Capital Market Perform Feb 23, 24
Morgan Stanley Equal-Weight Jan 23, 24
Morgan Stanley Equal-Weight Sep 25, 23
Wolfe Research Peer Perform May 9, 22